The store will not work correctly when cookies are disabled.
(R)-4-ethyl-9-(3-fluorophenethyl)-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one
ID: ALA4754130
PubChem CID: 118560969
Max Phase: Preclinical
Molecular Formula: C19H27FN2O2
Molecular Weight: 334.44
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CCN1CC2(CCN(CCc3cccc(F)c3)CC2)O[C@H](C)C1=O
Standard InChI: InChI=1S/C19H27FN2O2/c1-3-22-14-19(24-15(2)18(22)23)8-11-21(12-9-19)10-7-16-5-4-6-17(20)13-16/h4-6,13,15H,3,7-12,14H2,1-2H3/t15-/m1/s1
Standard InChI Key: MNYSMGPLHSJGLY-OAHLLOKOSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
36.7323 -3.7145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7282 -4.5317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4300 -4.9416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1403 -4.5388 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.1444 -3.7216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4382 -3.3072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3249 -2.8973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3249 -3.7145 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.0302 -4.1190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7355 -2.8973 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.0302 -2.4846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0302 -1.6674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6160 -2.4908 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.8454 -4.9520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5557 -4.5479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2608 -4.9611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2531 -5.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.9573 -6.1922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.6686 -5.7881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.6713 -4.9667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.9665 -4.5573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6188 -4.1246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9100 -3.7178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.3802 -4.5602 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
7 8 1 0
7 11 1 0
8 9 1 0
9 1 1 0
1 10 1 0
10 11 1 0
11 12 1 1
7 13 2 0
4 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
8 22 1 0
22 23 1 0
20 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 334.44 | Molecular Weight (Monoisotopic): 334.2057 | AlogP: 2.47 | #Rotatable Bonds: 4 |
Polar Surface Area: 32.78 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.41 | CX LogP: 2.10 | CX LogD: 1.06 |
Aromatic Rings: 1 | Heavy Atoms: 24 | QED Weighted: 0.85 | Np Likeness Score: -0.75 |
References
1. García M,Virgili M,Alonso M,Alegret C,Farran J,Fernández B,Bordas M,Pascual R,Burgueño J,Vidal-Torres A,Fernández de Henestrosa AR,Ayet E,Merlos M,Vela JM,Plata-Salamán CR,Almansa C. (2020) Discovery of EST73502, a Dual μ-Opioid Receptor Agonist and σ Receptor Antagonist Clinical Candidate for the Treatment of Pain., 63 (24): [PMID:33064947] [10.1021/acs.jmedchem.0c01127] |